Densitometric measurement of TF band in TF immunoblots were used to quantify relative TF antigen levels in cell extracts. == Immunofluorescence confocal microscopy == Cells cultured on glass coverslips were incubated with control vehicle, plasmin or thrombin for 30 min or 6 h at 37C. a factor Xa generation assay, TF antigen levels by immunoblot analysis and TF mRNA by Northern blot analysis. == Results == Both plasmin and Rabbit polyclonal to ZC3H12D thrombin treatments increased cell surface TF activity in HMC by 3 to 4-fold. In contrast to thrombin, plasmin-induced TF activity is not dependent on thede novosynthesis of TF. In HUVEC, plasmin had a minimal effect on Adenine sulfate unperturbed HUVEC whereas it markedly increased TF activity of activated HUVEC. Plasmin treatment neither affected anionic phospholipid levels at the cell surface nor released protein disulfide isomerase, an oxidoreductase protein that was newly described to play a role in TF activation. Plasmin cleaved cell-associated TFPI. == Conclusion == Thrombin Adenine sulfate upregulates TF activity in HMC through the transcriptional activation of TF whereas plasmin increases TF activity by inactivating Adenine sulfate the cell-associated TFPI by a limited proteolysis. Keywords:endothelial cells, mesothelial cells, plasmin, thrombin, tissue factor, tissue factor pathway inhibitor == Introduction == Formation of exudative pleural effusions and intrapleural fibrin deposition are hallmarks of a variety of inflammatory diseases affecting the lung pleura and malignant pleural mesothelioma [1;2]. Intrapleural fibrin deposition that bridges the visceral and parietal pleural surfaces characterizes fibrosing forms of pleuritis, such as those occur in association with complicated forms of parapneumonic effusions. If unchecked by the fibrinolytic system, the fibrinous intrapleural neomatrix leads to loculation that in turn organizes with pleural fibrosis [3]. Lung restriction and symptoms of persistent shortness of breath are common clinical sequellae. The mesothelial lining of pleura plays a central role in maintaining the hemostatic balance in pleura [4]. Human pleural mesothelial cells may autoregulate fibrin turnover locally by expression of procoagulants and fibrinolysins. Fibrin formation is resulted by the coagulation cascade activation initiated by tissue factor (TF), while the dissolution of fibrin is mediated by tissue plasminogen activator (tPA) and urokinase plasminogen activator (uPA)-dependent plasmin generation. Mesothelial cells express TF and the fibrinolysins, as well as plasminogen activator inhibitor-1 [5;6]. TF expression is typically found at low or undetectable levelsin vivoin the mesothelial lining of the normal pleura. Cultured mesothelial cells were shown to express low but measurable levels of tissue factor (TF) [7;8]. TF expression was shown to be upregulated, bothin vivoandin vitro, in response to inflammatory mediators or other pathophysiologically relevant stimuli [59]. However, our current knowledge is very limited regarding how TF expression is regulated in human pleural mesothelial cells (HMC). Tumor necrosis factor-alpha (TNF) was shown to increase TF mRNA expression levels in HMC [6]. Serum stimulation of quiescent HMC was found to induce both TF mRNA and TF activity levels by about 3-fold [7]. Interestingly, treating quiescent HMC with plasma resulted in a small but significant decrease in TF expression [7]. Pleural inflammation leads to increased microvascular permeability with formation of exudative effusions that contain plasma constituents. Albumin is the principal protein present in exudative pleural effusions, but coagulation and fibrinolytic proteins are also well represented in pleural effusions [4;1015]. Although active thrombin or plasmin was difficult to detect in most of the pleural fluids [4], there was a strong indication that they were generated in the pleural space. Coagulation factors necessary to generate thrombin, i.e., TF, FVII, FV, FX and prothrombin, procoagulant activity that is capable of shortening the clotting time upon recalcification of plasma deficient in factor VII, X, VIII, V or prothrombin, and high levels of prothrombin F1.2 fragments suggest that thrombin is generatedin Adenine sulfate vivoin pleural effusions [4;12]. The lack of readily detectable thrombin activity in most pleural fluids was thought to be due to the presence of high levels of antithrombin in pleural fluids [4]. Exudative pleural fluids were also shown to contain high levels of plasminogen and plasminogen activators [4;11;1315]. The presence of plasmin-derived peptides, plasmin-inhibitor complexes and high levels of fibrin degradation products including D-dimers provide evidence for the generation of plasminin vivoin pleural effusions [4;11;13;14]. In the.